|
I Clinical Issues and Tissue Processing |
|
|
1 | (54) |
|
Molecular Pathology Laboratory of the Future |
|
|
3 | (14) |
|
|
|
3 | (1) |
|
|
4 | (4) |
|
|
8 | (2) |
|
A Scenario of the Future of Tissue Diagnostics: A Prostate Biopsy for Assessment of Carcinoma |
|
|
10 | (4) |
|
Current Clinical Procedures |
|
|
10 | (1) |
|
Future Clinical Procedures |
|
|
11 | (3) |
|
|
14 | (3) |
|
|
14 | (3) |
|
Clinical Utilities of Microdissected Samples |
|
|
17 | (10) |
|
|
|
|
17 | (1) |
|
|
17 | (5) |
|
|
17 | (1) |
|
|
18 | (1) |
|
|
19 | (1) |
|
|
19 | (1) |
|
Assessment of Gene Copy Numbers |
|
|
20 | (1) |
|
Analysis of Cell Cycle Parameters |
|
|
21 | (1) |
|
|
22 | (1) |
|
Future Clinical Uses: Analysis of Cellular Proteins |
|
|
22 | (1) |
|
|
23 | (4) |
|
|
23 | (4) |
|
|
27 | (16) |
|
|
|
|
27 | (1) |
|
|
28 | (1) |
|
Sample Acquisition and Initial Tissue Handling |
|
|
28 | (1) |
|
Tissue Fixation and Snap-Freezing |
|
|
29 | (4) |
|
|
33 | (1) |
|
Evaluation of New Methods for Handling Clinical Tissue Specimens: Prostate Cancer as an Example of Tissue Handling for Molecular Analysis |
|
|
34 | (6) |
|
New Methods of Fixation/Embedding |
|
|
34 | (1) |
|
Nonformalin Tissue Fixation |
|
|
35 | (1) |
|
Comparison of Histology and Recovery of DNA, RNA, and Proteins |
|
|
36 | (4) |
|
Conclusions and Future Directions |
|
|
40 | (3) |
|
|
41 | (2) |
|
Sample Management and Tracking |
|
|
43 | (12) |
|
|
|
43 | (1) |
|
The Tissue Microdissection Core Laboratory: Organization and Basic Data Management |
|
|
43 | (3) |
|
Integrated Data Management for the Tissue-Oriented Biological Research: The Labmatrix System |
|
|
46 | (9) |
|
Labmatrix Primary Modules |
|
|
48 | (1) |
|
|
48 | (1) |
|
|
49 | (1) |
|
|
49 | (1) |
|
Workflow-Based Data Review: Functional Genomic Status Summarization Method |
|
|
50 | (1) |
|
|
50 | (1) |
|
Equipment and Supplies/Contacts |
|
|
51 | (1) |
|
Images/Configuration Tools |
|
|
51 | (1) |
|
|
51 | (1) |
|
Additional Features of Labmatrix Prototype |
|
|
52 | (1) |
|
Internal Proprietary and Public Reference Databases and Collaboration Features |
|
|
52 | (1) |
|
Data Security Features and Regulatory Compliance |
|
|
52 | (1) |
|
Integration with Other Scientific Tools and Technology |
|
|
52 | (3) |
|
II Methods of Tissue Microanalysis |
|
|
55 | (12) |
|
|
57 | (10) |
|
|
|
57 | (1) |
|
Construction of Tissue Microarrays |
|
|
57 | (1) |
|
Tissue Microarrays as a Validation Tool |
|
|
58 | (2) |
|
Immunohistochemistry and Tissue Microarrays |
|
|
60 | (3) |
|
In Situ Hybridization and Tissue Microarrays |
|
|
63 | (1) |
|
Image Capture and Data Analysis |
|
|
64 | (3) |
|
|
66 | (1) |
|
III Molecular Analysis of Micodissected Samples |
|
|
67 | (154) |
|
Methods of Microdissection and New Technologies |
|
|
69 | (32) |
|
|
|
|
|
|
|
|
|
69 | (2) |
|
Laser-Based Dissection Technologies |
|
|
71 | (3) |
|
Laser Capture Microdissection |
|
|
71 | (2) |
|
Palm Laser Microdissection and Pressure Catapulting Technology |
|
|
73 | (1) |
|
|
74 | (1) |
|
|
74 | (1) |
|
Expression Microdissection |
|
|
75 | (9) |
|
Future Directions of Expression Microdissection |
|
|
81 | (3) |
|
Layered Expression Scanning |
|
|
84 | (12) |
|
Open Layered Expression Scanning System |
|
|
86 | (1) |
|
|
87 | (2) |
|
|
89 | (1) |
|
Closed Layered Expression Scanning System |
|
|
90 | (2) |
|
Other Platforms for the Layered Expression Scanning Technique |
|
|
92 | (2) |
|
|
94 | (2) |
|
|
96 | (5) |
|
|
97 | (4) |
|
Standard Diagnostic Techniques |
|
|
101 | (10) |
|
|
|
101 | (1) |
|
Diagnostic Histopathology |
|
|
102 | (1) |
|
|
102 | (5) |
|
In Situ Hybridization and PCR-in situ Hybridization |
|
|
107 | (1) |
|
|
108 | (1) |
|
|
109 | (2) |
|
|
109 | (2) |
|
|
111 | (14) |
|
|
|
|
111 | (1) |
|
|
112 | (1) |
|
|
112 | (1) |
|
|
113 | (1) |
|
|
114 | (2) |
|
Single-Strand Conformation Polymorphism |
|
|
114 | (1) |
|
Restriction Fragment Length Polymorphism |
|
|
115 | (1) |
|
Gene Methylation Analysis |
|
|
116 | (1) |
|
|
117 | (3) |
|
|
117 | (1) |
|
|
118 | (1) |
|
|
118 | (1) |
|
X-Chromosome Inactivation |
|
|
118 | (2) |
|
Genotyping Assay of the D310 Repeat |
|
|
120 | (1) |
|
|
120 | (5) |
|
|
121 | (4) |
|
|
125 | (20) |
|
|
|
|
|
125 | (1) |
|
Tissue Selection for Gene Expression Analysis |
|
|
126 | (1) |
|
|
127 | (4) |
|
|
127 | (2) |
|
|
129 | (1) |
|
|
130 | (1) |
|
|
131 | (4) |
|
|
131 | (1) |
|
|
132 | (1) |
|
|
133 | (2) |
|
|
135 | (10) |
|
|
135 | (1) |
|
|
135 | (2) |
|
|
137 | (1) |
|
|
138 | (2) |
|
|
140 | (1) |
|
|
141 | (2) |
|
|
143 | (2) |
|
|
145 | (18) |
|
|
|
|
|
145 | (3) |
|
Laser Capture Microdissection |
|
|
148 | (1) |
|
|
149 | (4) |
|
Mass Spectrometry in Tissue Proteomics |
|
|
153 | (4) |
|
|
157 | (6) |
|
|
158 | (5) |
|
Protocols for Tissue Handling and Molecular Analysis |
|
|
163 | (58) |
|
Tissue Preparation for Prostate Prepared as Whole-Mount |
|
|
163 | (3) |
|
|
163 | (1) |
|
|
164 | (1) |
|
Low-Melt Polyester Embedding |
|
|
164 | (1) |
|
|
165 | (1) |
|
Slide Preparation for Microdissection to Perform Subsequent DNA, RNA, and Protein Analysis |
|
|
166 | (4) |
|
Slide Preparation for Laser Capture Microdissection |
|
|
166 | (1) |
|
Paraffin-Embedded Sections and Frozen Sections |
|
|
167 | (1) |
|
Low-Melt Polyester-Embedded Sections |
|
|
167 | (1) |
|
Slide Preparation for Manual Microdissection |
|
|
168 | (1) |
|
Paraffin-Embedded Sections and Frozen Sections |
|
|
169 | (1) |
|
Low-Melt Polyester-Embedded Sections |
|
|
170 | (1) |
|
Techniques of Microdissection |
|
|
170 | (3) |
|
Laser Capture Microdissection |
|
|
170 | (1) |
|
Immuno-Laser Capture Microdissection |
|
|
171 | (1) |
|
|
172 | (1) |
|
Processing of Microdissected Tissue for Molecular Analysis |
|
|
173 | (9) |
|
|
173 | (1) |
|
Protocol from Pathogenetics Unit |
|
|
173 | (2) |
|
DNA Extraction (Protocol from Wistuba) |
|
|
175 | (1) |
|
|
175 | (1) |
|
Isolation of Total RNA from Frozen Microdissected Tissue |
|
|
175 | (2) |
|
Protocol for Isolation of RNA from Frozen LCM Tissue (Protocol from Watson) |
|
|
177 | (2) |
|
Protocol for Isolation of RNA from Formalin-Fixed, Paraffin-Embedded LCM Tissue (Protocol from Watson) |
|
|
179 | (1) |
|
|
180 | (1) |
|
Sample Preparation for 2-D Page |
|
|
180 | (1) |
|
|
181 | (1) |
|
DNA, RNA, and Protein Analysis |
|
|
182 | (38) |
|
|
182 | (1) |
|
Clonality: X-Chromosome Inactivation |
|
|
182 | (3) |
|
|
185 | (5) |
|
DNA PCR Amplification (Protocol from Wistuba) |
|
|
190 | (1) |
|
Analysis of Microsatellite Markers (Protocol from Wistuba) |
|
|
191 | (1) |
|
Single-Strand Conformational Polymorphism (Protocol from Wistuba) |
|
|
192 | (1) |
|
Restricted Fragment Length Polymorphism (Protocol from Wistuba) |
|
|
192 | (1) |
|
Gene Methylation Analysis (Protocol from Wistuba) |
|
|
193 | (1) |
|
Genotyping Assay of the D310 Repeat (Protocol from Wistuba) |
|
|
193 | (1) |
|
In Situ Hybridization Protocol for Cytomegalovirus (Protocol from Gonzalez) |
|
|
194 | (1) |
|
|
195 | (1) |
|
|
195 | (2) |
|
Targeted Differential Display |
|
|
197 | (4) |
|
NonIsotopic in Situ Hybridization Protocol for mRNA Detection (Protocol from Gonzalez) |
|
|
201 | (1) |
|
Protocol for Transcript Amplification (Protocol from Watson) |
|
|
202 | (4) |
|
Protocol for RT-PCR Validation (Protocol from Watson) |
|
|
206 | (3) |
|
|
209 | (1) |
|
2-D Polyacrylamide Gel Electrophoresis |
|
|
209 | (5) |
|
|
214 | (2) |
|
|
216 | (4) |
|
Legal Issues, Informed Consent |
|
|
220 | (1) |
Subject Index |
|
221 | (4) |
Color Illustrations |
|
225 | |